Guest guest Posted September 26, 2007 Report Posted September 26, 2007 Northfield labs will still seek approval for blood substituteChicago Tribune Tue, 25 Sep 2007 10:27 AM PDTDespite failing to meet the primary goal of a critical clinical trial of its experimental blood substitute, the chief executive of an Evanston biotech company told its shareholders today that it will seek a speedy review by the Food and Drug Administration in the first half of next year for possible approval. Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.